These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 34272366)

  • 1. Structure of PDE3A-SLFN12 complex reveals requirements for activation of SLFN12 RNase.
    Garvie CW; Wu X; Papanastasiou M; Lee S; Fuller J; Schnitzler GR; Horner SW; Baker A; Zhang T; Mullahoo JP; Westlake L; Hoyt SH; Toetzl M; Ranaghan MJ; de Waal L; McGaunn J; Kaplan B; Piccioni F; Yang X; Lange M; Tersteegen A; Raymond D; Lewis TA; Carr SA; Cherniack AD; Lemke CT; Meyerson M; Greulich H
    Nat Commun; 2021 Jul; 12(1):4375. PubMed ID: 34272366
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanistic insights into cancer cell killing through interaction of phosphodiesterase 3A and schlafen family member 12.
    Wu X; Schnitzler GR; Gao GF; Diamond B; Baker AR; Kaplan B; Williamson K; Westlake L; Lorrey S; Lewis TA; Garvie CW; Lange M; Hayat S; Seidel H; Doench J; Cherniack AD; Kopitz C; Meyerson M; Greulich H
    J Biol Chem; 2020 Mar; 295(11):3431-3446. PubMed ID: 32005668
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure of PDE3A-SLFN12 complex and structure-based design for a potent apoptosis inducer of tumor cells.
    Chen J; Liu N; Huang Y; Wang Y; Sun Y; Wu Q; Li D; Gao S; Wang HW; Huang N; Qi X; Wang X
    Nat Commun; 2021 Oct; 12(1):6204. PubMed ID: 34707099
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiple PDE3A modulators act as molecular glues promoting PDE3A-SLFN12 interaction and induce SLFN12 dephosphorylation and cell death.
    Yan B; Ding Z; Zhang W; Cai G; Han H; Ma Y; Cao Y; Wang J; Chen S; Ai Y
    Cell Chem Biol; 2022 Jun; 29(6):958-969.e5. PubMed ID: 35104454
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of cancer-cytotoxic modulators of PDE3A by predictive chemogenomics.
    de Waal L; Lewis TA; Rees MG; Tsherniak A; Wu X; Choi PS; Gechijian L; Hartigan C; Faloon PW; Hickey MJ; Tolliday N; Carr SA; Clemons PA; Munoz B; Wagner BK; Shamji AF; Koehler AN; Schenone M; Burgin AB; Schreiber SL; Greulich H; Meyerson M
    Nat Chem Biol; 2016 Feb; 12(2):102-8. PubMed ID: 26656089
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phosphodiesterase 3A: a new player in development of interstitial cells of Cajal and a prospective target in gastrointestinal stromal tumors (GIST).
    Vandenberghe P; Hagué P; Hockman SC; Manganiello VC; Demetter P; Erneux C; Vanderwinden JM
    Oncotarget; 2017 Jun; 8(25):41026-41043. PubMed ID: 28454120
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Velcrin compounds activate the SLFN12 tRNase to induce tomoptosis.
    Greulich H
    Cell Chem Biol; 2024 Jun; 31(6):1039-1043. PubMed ID: 38906108
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Velcrin-induced selective cleavage of tRNA
    Lee S; Hoyt S; Wu X; Garvie C; McGaunn J; Shekhar M; Tötzl M; Rees MG; Cherniack AD; Meyerson M; Greulich H
    Nat Chem Biol; 2023 Mar; 19(3):301-310. PubMed ID: 36302897
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An alkaloid initiates phosphodiesterase 3A-schlafen 12 dependent apoptosis without affecting the phosphodiesterase activity.
    Ai Y; He H; Chen P; Yan B; Zhang W; Ding Z; Li D; Chen J; Ma Y; Cao Y; Zhu J; Li J; Ou J; Du S; Wang X; Ma J; Gao S; Qi X
    Nat Commun; 2020 Jun; 11(1):3236. PubMed ID: 32591543
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting tumor cells based on Phosphodiesterase 3A expression.
    Nazir M; Senkowski W; Nyberg F; Blom K; Edqvist PH; Jarvius M; Andersson C; Gustafsson MG; Nygren P; Larsson R; Fryknäs M
    Exp Cell Res; 2017 Dec; 361(2):308-315. PubMed ID: 29107068
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PDE3A inhibitor anagrelide activates death signaling pathway genes and synergizes with cell death-inducing cytokines to selectively inhibit cancer cell growth.
    An R; Liu J; He J; Wang F; Zhang Q; Yu Q
    Am J Cancer Res; 2019; 9(9):1905-1921. PubMed ID: 31598394
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A complex puzzle: Regulation of SLFN12 RNase activity by phosphorylation.
    Greulich H
    Cell Chem Biol; 2022 Jun; 29(6):925-927. PubMed ID: 35714590
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimization of PDE3A Modulators for SLFN12-Dependent Cancer Cell Killing.
    Lewis TA; de Waal L; Wu X; Youngsaye W; Wengner A; Kopitz C; Lange M; Gradl S; Ellermann M; Lienau P; Schreiber SL; Greulich H; Meyerson M
    ACS Med Chem Lett; 2019 Nov; 10(11):1537-1542. PubMed ID: 31749907
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estrogen-Related Hormones Induce Apoptosis by Stabilizing Schlafen-12 Protein Turnover.
    Li D; Chen J; Ai Y; Gu X; Li L; Che D; Jiang Z; Li L; Chen S; Huang H; Wang J; Cai T; Cao Y; Qi X; Wang X
    Mol Cell; 2019 Sep; 75(6):1103-1116.e9. PubMed ID: 31420216
    [TBL] [Abstract][Full Text] [Related]  

  • 15. cUMP hydrolysis by PDE3A.
    Berrisch S; Ostermeyer J; Kaever V; Kälble S; Hilfiker-Kleiner D; Seifert R; Schneider EH
    Naunyn Schmiedebergs Arch Pharmacol; 2017 Mar; 390(3):269-280. PubMed ID: 27975297
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of overlapping but distinct cAMP and cGMP interaction sites with cyclic nucleotide phosphodiesterase 3A by site-directed mutagenesis and molecular modeling based on crystalline PDE4B.
    Zhang W; Ke H; Tretiakova AP; Jameson B; Colman RW
    Protein Sci; 2001 Aug; 10(8):1481-9. PubMed ID: 11468344
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Partial characterization of the active site human platelet cAMP phosphodiesterase, PDE3A, by site-directed mutagenesis.
    Cheung PP; Yu L; Zhang H; Colman RW
    Arch Biochem Biophys; 1998 Dec; 360(1):99-104. PubMed ID: 9826434
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutations in Phosphodiesterase 3A (
    Ercu M; Walter S; Klussmann E
    Hypertension; 2023 Jun; 80(6):1171-1179. PubMed ID: 37035914
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    Toivanen K; Kilpinen S; Ojala K; Merikoski N; Salmikangas S; Sampo M; Böhling T; Sihto H
    Cancers (Basel); 2023 Nov; 15(22):. PubMed ID: 38001568
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isoforms of cyclic nucleotide phosphodiesterase PDE3 and their contribution to cAMP hydrolytic activity in subcellular fractions of human myocardium.
    Hambleton R; Krall J; Tikishvili E; Honeggar M; Ahmad F; Manganiello VC; Movsesian MA
    J Biol Chem; 2005 Nov; 280(47):39168-74. PubMed ID: 16172121
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.